Over the past year, we’ve seen a sea change in drug discovery — from the adoption of AI & advanced automation to changes in the funding landscape and talent space. In our State of Play: 2025 report, we lay it all out for you.
BioPharma State of Play: 2025 Read More »
This year saw a return to major industry events. Highlights included attending BioPharma PM, BioIT World, and BIO conferences and showcasing our Pipeline Program Management software. We launched a successful “Roadmap Informatics & Laboratory Planning Service” and completed significant client projects, including Diagnostics LIMS System, DEL Library Design & Screening, and Automated Synthesis modules.
Year in Review | Aspen Biosciences Read More »
Whether you’re in the lab running an experiment, taking that morning jog around the mesa as your experiment runs, or making the drive into work, there are always lots of opportunities to stay up to date with the latest news from the biotech industry. Here’s what we’ve been listening to lately: TWIV: This Week In
What’s on Our Podcast Playlist? Read More »
I recently found myself catching up on tweets, and I came across this repost by Michael Gilman, CEO of Arrakis Therapeutics, and I was reminded that over the past 20 years we’ve seen an explosive redefinition of the edges of druggable space. The nucleus of that explosion was the human genome project. In my own
Expanding Druggable Space Read More »
My mother’s love for books mirrored the nation’s renewed interest in Defoe’s “A Journal of the Plague Year” during the COVID-19 pandemic. This year highlighted the rapid development of mRNA therapeutics, innovative drug discovery, and our community efforts to support those affected by the crisis.
Aspen Biosciences: A Year of Innovation, Adversity, and Community Engagement Read More »
Things have been pretty busy this month at Pharm2Market as we continue to grow our business intelligence service in the communities we serve.
Pharm2Market April Newsletter Read More »
We take a look at the San Francisco drug discovery community and the stats behind the business development, investment, and partnering opportunities.
San Francisco By The Numbers Read More »
The new year has begun, and with it the search for new customers. We spoke with local biotech business development professionals to learn more about the detective-work they do to find new customers. Here’s what we learned.
Pharm2Market – Watching The Detectives Read More »
